Bli medlem
Bli medlem

Du är här


Weifa ASA : Minutes from the EGM

Oslo, Norway, 17 April 2015

Weifa ASA (OSE: WEIFA), reference is made to the announcements on 13 March
2015 regarding the proposal to separate the Company's consumer health and
business-to-business ("B2B") operations through a sale of its B2B business
and tablet production to Vistin Pharma, a newly established subsidiary of
Weifa, which will seek listing on Oslo Axess.

Please find attached the Minutes from the Extraordinary General Meeting to
approve the sale, which was held in Oslo on 16 August 2014. All matters were
resolved as proposed in the Notice to the General Meeting.


Gunnar Manum
+47 95 17 91 90

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Minutes from EGM in Weifa ASA


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Weifa ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.